Re: Joint Venture TransactionTitanium Healthcare, Inc. • November 13th, 2015 • Retail-drug stores and proprietary stores
The purpose of this letter of intent ("Letter") is to set forth certain agreements between Titanium Healthcare, Inc.,a Nevada corporation ("Titanium"), a to-be-formed joint venture subsidiary called "ODIN Applied Research Laboratories, Inc.", a Texas limited liability company or "OARL", and ODIN Industries, a Georgia limited liability company ("ODIN") with respect to the business combination of certain capabilities of Titanium and ODIN into a mutually owned entity OARL (the "Joint Venture" or "JV"), on the terms and subject to the conditions set forth below.
Re: Joint Venture TransactionTitanium Healthcare, Inc. • November 13th, 2015 • Retail-drug stores and proprietary stores
The purpose of this letter of intent ("Letter") is to set forth certain agreements between Titanium Healthcare, Inc.,a Nevada corporation ("Titanium"), LBData, LLC, a Texas limited liability company ("LBDATA"), Wave Quantum, LLC, a Texas limited liability company or ("Wave Quantum"), and a to-be-formed joint venture called "Elluminance LLC", a Texas limited liability company or ("Elluminance"), with respect to the business combination of certain capabilities of Titanium, Wave Quantum, and LBDATA into a mutually owned entity Elluminance (the "Joint Venture" or "JV"), on the terms and subject to the conditions set forth below.
